PATENT CLAIM ANALYSIS

Application Number: 15917137
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "021500"]

Abstract:
The present invention provides peptide compounds that regulate the complement system and methods of using these compounds. The invention is an isolated, purified peptide of 30 amino acids derived from human astrovirus protein, called CP1. The invention is directed to peptide compounds that are peptide mimetics, peptide analogs and/or synthetic derivatives of CP1 having, for example, internal peptide deletions and substitutions, deletions and substitutions at the N-terminus and C-terminus, and that are able to regulate complement activation. The invention further provides pharmaceutical compositions of therapeutically effective amounts of the peptide compounds and a pharmaceutically acceptable carrier, diluent, or excipient for treating a disease or condition associated with complement-mediated tissue damage.

Claim (Index 28):
The method of  claim 25 , wherein the disease is ischemia-reperfusion injury (IRI).

Metadata:
- Claim Count in Document: 64.0
- Percentile: 90.0
- Lexical Diversity: 1.70833
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14536073', '13809371', '15203469', '15192934', '14951565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8299419878921627
- 35 USC 102 Novelty (BERT): 0.5605604778808356
- Combined Prediction Score: 0.80300383689103
- Mean Citation Score: 512.1488099999998
- Max Citation Score: 611.1261
- Similarity Product: 280.33618263373376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test